Guided selection of human antibody light chains against TAG-72 using a phage display chain shuffling approach

Journal of Microbiology

Volumn 45, Issue 6, 2007, Pages 572-577

  Sang, Jick Kim ^a   Hyo, Jeong Hong ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Chain shuffling; Guided selection; Monoclonal antibody; Phage display; TAG 72

Indexed keywords

GLYCOPROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN 72; TUMOR-ASSOCIATED ANTIGEN 72; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN COS1; CERCOPITHECUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; IMMUNOLOGY; KINETICS; METABOLISM; MOUSE; PROTEIN BINDING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; KINETICS; MICE; PEPTIDE LIBRARY; PROTEIN BINDING;

MURINAE;

EID: 37549011828     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Beiboer, S.H., A. Reurs, R.C. Roovers, J.W. Arends, N.R. Whitelegg, A.R. Rees, and H.R. Hoogenboom. 2000. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent. J. Mol. Biol. 296, 833-849.
2. Burton, D.R., C.F. Barbas, 3rd, M.A. Persson, S. Koenig, R.M. Chanock, and R.A. Lerner. 1991. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88, 10134-10137.
3. De Pascalis, R., N.R. Gonzales, E.A. Padlan, P. Schuck, S.K. Batra, J. Schlom, and S.V. Kashmiri. 2003. In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: isolation and characterization of minimally immunogenic high-affinity variants. Clin. Cancer Res. 9, 5521-5531.
4. Divgi, C.R., A.M. Scott, L. Dantis, P. Capitelli, K. Siler, S. Hilton, R.D. Finn, N. Kemeny, D. Kelsen, L. Kostakoglu, J. Schlom, and S.M. Larson. 1995a. Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma. J. Nucl. Med. 36, 586-592.
5. Divgi, C.R., A.M. Scott, S. Gulec, E.K. Broussard, N. Levy, C. Young, P. Capitelli, F. Daghighian, J.M. Williams, and R.D. Finn. 1995b. Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma. Clin. Cancer Res. 1, 1503-1510.
6. Divgi, C.R., A.M. Scott, K. McDermott, P.S. Fallone, S. Hilton, K. Siler, N. Carmichael, F. Daghighian, R.D. Finn, A.M. Cohen, J. Schlom, and S.M. Larson. 1994. Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigen. Nucl. Med. Biol. 21, 9-15.
7. Figini, M., J.D. Marks, G. Winter, and A.D. Griffiths. 1994. In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation. J. Mol. Biol. 239, 68-78.
8. Figini, M., L. Obici, D. Mezzanzanica, A. Griffiths, M.I. Colnaghi, G. Winter, and S. Canevari. 1998. Panning phage antibody libraries on cells: isolation of human Fab fragments against ovarian carcinoma using guided selection. Cancer Res. 58, 991-996.
9. Gonzales, N.R., E.A. Padlan, R. De Pascalis, P. Schuck, J. Schlom, and S.V. Kashmiri. 2003. Minimizing immunogenicity of the SDR-grafted humanized antibody CC49 by genetic manipulation of the framework residues. Mol. Immunol. 40, 337-349.
10. Iwahashi, M., D.E. Milenic, E.A. Padlan, R. Bei, J. Schlom, and S.V. Kashmiri. 1999. CDR substitutions of a humanized monoclonal antibody (CC49): contributions of individual CDRs to antigen binding and immunogenicity. Mol. Immunol. 36, 1079-1091.
11. Jespers, L.S., A. Roberts, S.M. Mahler, G. Winter, and H.R. Hoogenboom. 1994. Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Bio/Technol. 12, 899-903.
12. Kashmiri, S.V., L. Shu, E.A. Padlan, D.E. Milenic, J. Schlom, and P.H. Hand. 1995. Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49. Hybridoma 14, 461-473.
13. Kim, S.J., M.H. Jang, J.T. Stapleton, S.O. Yoon, K.S. Kim, E.S. Jeon, and H.J. Hong. 2004. Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display. Virology 318, 598-607.
14. Marks, J.D., H.R. Hoogenboom, T.P. Bonnert, J. McCafferty, A.D. Griffiths, and G. Winter. 1991. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222, 581-597.
15. Mulligan, T., J.A. Carrasquillo, Y. Chung, D.E. Milenic, J. Schlom, I. Feuerstein, C. Paik, P. Perentesis, J. Reynolds, and G. Curt. 1995. Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma. Clin. Cancer Res. 1, 1447-1454.
16. Pavlinkova, G., D. Colcher, B.J. Booth, A. Goel, and S.K. Batra. 2000. Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct. Cancer Immunol. Immunother. 49, 267-275.
17. Persson, M.A., R.H. Caothien, and D.R. Burton. 1991. Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc. Natl. Acad. Sci. USA 88, 2432-2436.
18. Tamura, M., D.E. Milenic, M. Iwahashi, E. Padlan, J. Schlom, and S.V. Kashmiri. 2000. Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only. J. Immunol. 164, 1432-1441.
19. Thor, A., R. Muraro, F. Gorstein, N. Ohuchi, M. Viglione, C.A. Szpak, W.W. Johnston, and J. Schlom. 1987. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity. Cancer Res. 47, 505-512.
20. Thor, A., N. Ohuchi, C.A. Szpak, W.W. Johnston, and J. Schlom. 1986. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res. 46, 3118-3124.
21. Watzka, H., K. Pfizenmaier, and D. Moosmayer. 1998. Guided selection of antibody fragments specific for human interferon gamma receptor 1 from a human VH- and VL-gene repertoire. Immunotechnology 3, 279-291.
22. Yoon, S.O., T.S. Lee, S.J. Kim, M.H. Jang, Y.J. Kang, J.H. Park, K.S. Kim, H.S. Lee, C.J. Ryu, N.R. Gonzales, S.V. Kashmiri, S.M. Lim, C.W. Choi, and H.J. Hong. 2006. Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody. J. Biol. Chem. 281, 6985-6992.